Form4insider filings, from the source

SEC Form 4 · accession 0000886163-18-000046

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jason Aryeh
Director
Period of report
Mar 8, 2018
Accepted (ET)
Mar 9, 2018 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 8, 2018S3,500$174.8843D83,334IIndirect
Common StockF3,F2Mar 9, 2018S4,000$176.4747D79,334IIndirect
Common Stockholding———58,625D
Common Stockholding———5,025Iby Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses